Beijing Saier Biopharmaceutical

Beijing Saier Biopharmaceutical is a Chinese biotechnology company specializing in the research, development, and clinical application of regenerative medicine and cell-based therapies. The company focuses on utilizing mesenchymal stem cells (MSCs) and natural killer (NK) cells to treat a wide range of chronic and refractory conditions, including liver cirrhosis, autoimmune disorders, and neurological injuries. Saier Biopharmaceutical operates integrated facilities for cell storage, preparation, and quality control, adhering to regional regulatory standards for cellular products. By leveraging its proprietary cell processing technologies, the company aims to provide innovative therapeutic solutions for diseases with significant unmet medical needs in the Chinese market.